Candidate Human Genetic Polymorphisms and Severe Malaria in a Tanzanian Population

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Manjurano, Alphaxard ^a,b   Clark, Taane G ^b   Nadjm, Behzad ^a,b   Mtove, George ^a   Wangai, Hannah ^a   Sepulveda, Nuno ^b   Campino, Susana G ^c   Maxwell, Caroline ^b   Olomi, Raimos ^a   Rockett, Kirk R ^d   Jeffreys, Anna ^d   Riley, Eleanor M ^b   Reyburn, Hugh ^a,b   Drakeley, Christopher ^a,b  

^a KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; LACTIC ACID; TRIPARTITE MOTIF PROTEIN 5;

ACIDOSIS; ADENYL CYCLASE 9 GENE; ALPHA THALASSEMIA GENE; ANEMIA; ARTICLE; BRAIN MALARIA; CD40L GENE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; G6PD GENE; GENE DELETION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HUMAN; IL 13 GENE; IL 1ALPHA GENE; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALARIA; MALE; MASS SPECTROMETRY; PRESCHOOL CHILD; PREVALENCE; RESPIRATORY DISTRESS; RETICULON 13 GENE; SCHOOL CHILD; SEVERE MALARIAL ANEMIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TANZANIA; TRIM5 GENE;

ADENYLATE CYCLASE; CARRIER PROTEINS; CD40 LIGAND; CHILD; CHILD, PRESCHOOL; FEMALE; GENES, X-LINKED; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; INFANT; INTERLEUKIN-13; INTERLEUKIN-1ALPHA; LOGISTIC MODELS; MALARIA, FALCIPARUM; MALE; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; TANZANIA;

EID: 84868092905     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047463     Document Type: Article

References (64)

1. Organization WH (2010) World malaria report. Geneva: World Health Organization, Available: http://whqlibdoc.who.int/publications/2010/9789241564106_eng.pdf.
2. Organization WH, (2010) Weekly epidemiological record. Weekly epidemiological record pp. 229-236.
3. Organization WH, (2010c) Weekly epidemiological record. 85: 461-472.
4. Crawley J, Chu C, Mtove G, Nosten F, (2010) Malaria in children. Lancet 375: 1468-1481.
5. Organisation WH (2011) World Malaria Report 2011.
6. Greenwood B, Marsh K, Snow R, (1991) Why do some African children develop severe malaria? Parasitol Today 7: 277-281.
7. Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN, (2005) Heritability of malaria in Africa. PLoS Med 2: e340.
8. Campino S, Kwiatkowski D, Dessein A, (2006) Mendelian and complex genetics of susceptibility and resistance to parasitic infections. Semin Immunol 18: 411-422.
9. Enevold A, Alifrangis M, Sanchez JJ, Carneiro I, Roper C, et al. (2007) Associations between alpha+-thalassemia and Plasmodium falciparum malarial infection in northeastern Tanzania. J Infect Dis 196: 451-459.
10. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, et al. (2009) Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 41: 657-665.
11. Guindo A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA, (2007) X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med 4: e66.
12. Fry AE, Griffiths MJ, Auburn S, Diakite M, Forton JT, et al. (2008) Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum Mol Genet 17: 567-576.
13. Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, et al. (2007) Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A 104: 17471-17476.
14. Artavanis-Tsakonas K, Tongren JE, Riley EM, (2003) The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin Exp Immunol 133: 145-152.
15. Clark TG, Diakite M, Auburn S, Campino S, Fry AE, et al. (2009) Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations. J Infect Dis 199: 569-575.
16. Mockenhaupt FP, Hamann L, von Gaertner C, Bedu-Addo G, von Kleinsorgen C, et al. (2006) Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. J Infect Dis 194: 184-188.
17. Sabeti P, Usen S, Farhadian S, Jallow M, Doherty T, et al. (2002) CD40L association with protection from severe malaria. Genes Immun 3: 286-291.
18. Stevenson MM, Riley EM, (2004) Innate immunity to malaria. Nat Rev Immunol 4: 169-180.
19. Clark IA, Rockett KA, (1996) Nitric oxide and parasitic disease. Adv Parasitol 37: 1-56.
20. Maxwell CA, Chambo W, Mwaimu M, Magogo F, Carneiro IA, et al. (2003) Variation of malaria transmission and morbidity with altitude in Tanzania and with introduction of alphacypermethrin treated nets. Malar J 2: 28.
21. Mtove G, Nadjm B, Hendriksen IC, Amos B, Muro F, et al. (2011) Point-of-care measurement of blood lactate in children admitted with febrile illness to an African District Hospital. Clin Infect Dis 53: 548-554.
22. Nadjm B, Amos B, Mtove G, Ostermann J, Chonya S, et al. (2010) WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective study. BMJ 340: c1350.
23. Zhang L, Cui X, Schmitt K, Hubert R, Navidi W, et al. (1992) Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci U S A 89: 5847-5851.
24. Gonzalez JM, Portillo MC, Saiz-Jimenez C, (2005) Multiple displacement amplification as a pre-polymerase chain reaction (pre-PCR) to process difficult to amplify samples and low copy number sequences from natural environments. Environ Microbiol 7: 1024-1028.
25. Ross P, Hall L, Smirnov I, Haff L, (1998) High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat Biotechnol 16: 1347-1351.
26. Wilson JN, Rockett K, Jallow M, Pinder M, Sisay-Joof F, et al. (2005) Analysis of IL10 haplotypic associations with severe malaria. Genes Immun 6: 462-466.
27. Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, et al. (2000) Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol 108: 295-299.
28. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA, (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70: 425-434.
29. Teo YY, Small KS, Fry AE, Wu Y, Kwiatkowski DP, et al. (2009) Power consequences of linkage disequilibrium variation between populations. Genet Epidemiol 33: 128-135.
30. Diakite M, Clark TG, Auburn S, Campino S, Fry AE, et al. (2009) A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility. Hum Genet 125: 105-109.
31. Fowkes FJ, Allen SJ, Allen A, Alpers MP, Weatherall DJ, et al. (2008) Increased microerythrocyte count in homozygous alpha(+)-thalassaemia contributes to protection against severe malarial anaemia. PLoS Med 5: e56.
32. Veenemans J, Andang'o PE, Mbugi EV, Kraaijenhagen RJ, Mwaniki DL, et al. (2008) Alpha+-thalassemia protects against anemia associated with asymptomatic malaria: evidence from community-based surveys in Tanzania and Kenya. J Infect Dis 198: 401-408.
33. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, et al. (1995) Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376: 246-249.
34. Allison AC, Clyde DF, (1961) Malaria in African children with deficient erythrocyte glucose-6-phosphate dehydrogenase. Br Med J 1: 1346-1349.
35. Bienzle U, Ayeni O, Lucas AO, Luzzatto L, (1972) Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with non-deficient variant. Lancet 1: 107-110.
36. Clark TG, Fry AE, Auburn S, Campino S, Diakite M, et al. (2009) Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. Eur J Hum Genet 17: 1080-1085.
37. Harrison T, Samuel BU, Akompong T, Hamm H, Mohandas N, et al. (2003) Erythrocyte G protein-coupled receptor signaling in malarial infection. Science 301: 1734-1736.
38. Murphy SC, Harrison T, Hamm HE, Lomasney JW, Mohandas N, et al. (2006) Erythrocyte G protein as a novel target for malarial chemotherapy. PLoS Med 3: e528.
39. Auburn S, Fry AE, Clark TG, Campino S, Diakite M, et al. (2010) Further evidence supporting a role for gs signal transduction in severe malaria pathogenesis. PLoS One 5: e10017.
40. Auburn S, Diakite M, Fry AE, Ghansah A, Campino S, et al. (2008) Association of the GNAS locus with severe malaria. Hum Genet 124: 499-506.
41. Goldberg R, Reshef-Bankai E, Coleman R, Green J, Maor G, (2006) Chronic acidosis-induced growth retardation is mediated by proton-induced expression of Gs protein. J Bone Miner Res 21: 703-713.
42. Couper KN, Blount DG, Riley EM, (2008) IL-10: the master regulator of immunity to infection. J Immunol 180: 5771-5777.
43. Linke A, Kuhn R, Muller W, Honarvar N, Li C, et al. (1996) Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp Parasitol 84: 253-263.
44. Dodoo D, Omer FM, Todd J, Akanmori BD, Koram KA, et al. (2002) Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis 185: 971-979.
45. Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, et al. (1998) Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351: 1768-1772.
46. Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, et al. (1999) A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis 179: 279-282.
47. Couper KN, Blount DG, Wilson MS, Hafalla JC, Belkaid Y, et al. (2008) IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog 4: e1000004.
48. Walther M, Jeffries D, Finney OC, Njie M, Ebonyi A, et al. (2009) Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog 5: e1000364.
49. Ouma C, Davenport GC, Were T, Otieno MF, Hittner JB, et al. (2008) Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum Genet 124: 515-524.
50. Zhang G, Manaca MN, McNamara-Smith M, Mayor A, Nhabomba A, et al. (2012) Interleukin-10 (IL-10) polymorphisms are associated with IL-10 production and clinical malaria in young children. Infect Immun 80: 2316-2322.
51. Velavan TP, Buyukyazici B, Kremsner PG, Kun JF, (2012) Combined promoter haplotypes of the IL10R genes are associated with protection against severe malaria in Gabonese children. Immunogenetics 64: 87-95.
52. Cui L, Jia J, Ma CF, Li SY, Wang YP, et al. (2012) IL-13 polymorphisms contribute to the risk of asthma: a meta-analysis. Clin Biochem 45: 285-288.
53. Smith AJ, Humphries SE, (2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 20: 43-59.
54. Grant AV, Araujo MI, Ponte EV, Oliveira RR, Gao P, et al. (2012) Functional polymorphisms in IL13 are protective against high Schistosoma mansoni infection intensity in a Brazilian population. PLoS One 7: e35863.
55. Naka I, Nishida N, Patarapotikul J, Nuchnoi P, Tokunaga K, et al. (2009) Identification of a haplotype block in the 5q31 cytokine gene cluster associated with the susceptibility to severe malaria. Malar J 8: 232.
56. Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Looareesuwan S, et al. (2003) A single-nucleotide substitution from C to T at position-1055 in the IL-13 promoter is associated with protection from severe malaria in Thailand. Genes Immun 4: 528-531.
57. Carpenter D, Abushama H, Bereczky S, Farnert A, Rooth I, et al. (2007) Immunogenetic control of antibody responsiveness in a malaria endemic area. Hum Immunol 68: 165-169.
58. Pertel T, Hausmann S, Morger D, Zuger S, Guerra J, et al. (2011) TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472: 361-365.
59. Nakayama EE, Shioda T, (2012) Role of Human TRIM5alpha in Intrinsic Immunity. Front Microbiol 3: 97.
60. Lukic Z, Hausmann S, Sebastian S, Rucci J, Sastri J, et al. (2011) TRIM5alpha associates with proteasomal subunits in cells while in complex with HIV-1 virions. Retrovirology 8: 93.
61. Wakana Y, Koyama S, Nakajima K, Hatsuzawa K, Nagahama M, et al. (2005) Reticulon 3 is involved in membrane trafficking between the endoplasmic reticulum and Golgi. Biochem Biophys Res Commun 334: 1198-1205.
62. Heath JE, Siedlak SL, Zhu X, Lee HG, Thakur A, et al. (2010) Widespread distribution of reticulon-3 in various neurodegenerative diseases. Neuropathology 30: 574-579.
63. Delahaye NF, Coltel N, Puthier D, Barbier M, Benech P, et al. (2007) Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice. BMC Genomics 8: 452.
64. Toure O, Konate S, Sissoko S, Niangaly A, Barry A, et al. (2012) Candidate polymorphisms and severe malaria in a malian population. PLoS One 7: e43987.